- Home
- ESEA vs OSUR Comparison
ESEA vs OSUR Comparison
Compare ESEA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESEA | OSUR |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 389.3M | 214.1M |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ESEA | OSUR |
|---|---|---|
| Price | $68.00 | $3.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $62.00 | $3.00 |
| AVG Volume (30 Days) | 65.7K | ★ 518.1K |
| Earning Date | 02-25-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.58% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $1.78 | $4.48 |
| Revenue Next Year | $1.03 | $7.76 |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.30 | $2.08 |
| 52 Week High | $72.87 | $3.76 |
Technical Indicators
Market Signals| Indicator | ESEA | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 54.54 |
| Support Level | $51.63 | $3.05 |
| Resistance Level | $72.87 | $3.38 |
| Average True Range (ATR) | 3.30 | 0.19 |
| MACD | -0.31 | -0.02 |
| Stochastic Oscillator | 63.47 | 41.79 |
Price Performance
Historical ComparisonAbout ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.